Vacancy in Jubilant Generics

Vacancy in Jubilant Generics | Production

Position :- Officer-Production

Company :- Jubilant Generics Limited

Location :- Saharanpur, Uttar Pradesh, India

Job Description :-
Jubilant Pharma Limited is a global integrated
pharmaceutical company offering a wide range of
products and services to its Customers across
geographies.

We organise our business into two segments, namely, Specialty Pharmaceuticals, comprising
Radiopharmaceuticals (including Radio pharmacies),
Contract Manufacturing of Sterile Injectable, Non-sterile &Products Allergy Therapy Products, and Generics & APls, comprising
Solid Dosage Formulations & Active Pharmaceutical
Ingredients.

Jubilant Generics (JGL) is a wholly – owned subsidiary of
Jubilant Pharma.

JGL in India has Research &
Development units at Noida and Mysore.

It has two manufacturing facilities one at Mysore, Karnataka and
another at Roorkee, Uttarakhand, engaged in APls and Dosage manufacturing, respectively.

The manufacturing location at Mysore is spread over 69
acres and it’s a USFDA approved site engaged in
manufacturing of APls, and caters to the sales worldwide.

APl portfolio focusses on Lifestyle driven Therapeutic
Areas (CVS, CNS) and targets complex and newly
approved molecules.

The company is the market leader in
four APls and is amongst the top three players for another
three APls in its portfolio helping it maintain a high
contribution margin.

The manufacturing location at Roorkee, Uttarakhand is state of the art facility and is
audited and approved by USFDA, Japan PMDA, UK MHRA,
TGA, WHO and Brazil ANVISA.

This business focusses on

Both manufacturing units are backward- integrated and
are supported by around 500 research and development
professionals based at Noida and Mysore. R&D works on
Development of new products in API, Solid Dosage
Formulations of Oral Solid, Sterile Injectable, Semi-Solids
Ointments, Creams and Liquids.

All BA/BE studies are
done In house at our 80 Bed facility which is inspected
and having approvals /certifications from The Drugs
Controller General (India) and has global regulatory
accreditations including USFDA, EMEA, ANVISA (Brazil),
INFRAMED (Portugal Authority), NPRA(Malaysia), AGES MEA (Austria) for GCP and NABL, CAP accreditations for
Path lab services.

JGL’s full-fledged Regulatory Affairs & IPR professionals
ensures unique portfolio of patents and product filings in
regulatory and non-regulatory market.

Revenue of Jubilant Pharma is constantly increasing and
during the Financial Year 2018 -19 it was INR 53,240
Million as compared to INR 39,950 Million during the
Financial Year 2017-18.